LAB Deferred Revenue

Standard Biotools Inc · Deferred Revenue

LAB logo

LAB Deferred Revenue

Latest reported$38.95M
LAB FY Deferred Revenue ($1.01M → $38.95M)
High-resolution chart · PNG

LAB deferred revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Standard Biotools Inc Deferred Revenue — Annual fiscal periods (USD)
Period endingDeferred Revenue (USD)
38,949,000
18,585,000
16,735,000
14,436,000
15,482,000
16,387,000
11,803,000
11,464,000
10,238,000
9,163,000
9,419,000
6,928,000
2,721,000
1,886,000
2,011,000
1,336,000
758,000
1,412,000
2,652,000
1,010,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.